Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $292.5600 (0.25%) ($287.6600 - $295.4900) on Fri. Jul. 12, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.01% (three month average) | | RSI | 31 | | Latest Price | $292.5600(0.25%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.2% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -1.005% in a week (0% probabilities).
VIXM(-25%) VXX(-11%) IFRA(-7%) TLT(-6%) TIP(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.005% (StdDev 2.01%) | | Hourly BBV | 0 () | | Intraday Trend | 0.2% | | | | | |
|
| Resistance Level | $308.92 | | 5 Day Moving Average | $299.32(-2.26%) | | 10 Day Moving Average | $306.25(-4.47%) | | 20 Day Moving Average | $308.92(-5.3%) | | To recent high | -23.6% | | To recent low | 0.3% | | Market Cap | $31.02b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |